We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
-23.97%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.26B
AUM Growth
-$359M
(-22%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
10.35%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
929
New
226
Increased
255
Reduced
141
Closed
293
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$27.2M |
| 2 |
EOG Resources
EOG
|
+$17.7M |
| 3 |
Lyft
LYFT
|
+$10.9M |
| 4 |
GE Aerospace
GE
|
+$10.5M |
| 5 |
Apple
AAPL
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.8M |
| 2 |
SMAR
Smartsheet Inc.
SMAR
|
+$10.2M |
| 3 |
ServiceNow
NOW
|
+$9.31M |
| 4 |
Hilton Worldwide
HLT
|
+$9.17M |
| 5 |
Paylocity
PCTY
|
+$8.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.51% |
| 2 | Technology | 16.97% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Industrials | 10.47% |
| 5 | Financials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Arcus Biosciences
RCUS
$3.55B
| $236K | 0.02% |
17,033
-2,529
| -13% | -$31.5K |
|
527
Teekay
TK
$983M
| $236K | 0.02% |
74,768
-25
| -0% | -$90 |
|
528
Columbia Financial
CLBK
$1.14B
| $235K | 0.02% |
16,325
-3,703
| -18% | -$59.2K |
|
529
Lindsay Corp
LNN
$1.12B
| $235K | 0.02% |
+2,563
| New | +$253K |
|
530
Prothena Corp
PRTA
$440M
| $230K | 0.02% |
21,500
| – | – |
|
531
Willdan Group
WLDN
$1.06B
| $228K | 0.02% |
10,680
-1,381
| -11% | -$42.5K |
|
532
Viavi Solutions
VIAV
$8.65B
| $227K | 0.02% |
20,211
+111
| +0.6% | +$1.51K |
|
|
GNMK
533
DELISTED
GenMark Diagnostics, Inc
GNMK
| $227K | 0.02% |
55,100
+12,600
| +30% | +$59.1K |
|
534
First Merchants
FRME
$2.69B
| $226K | 0.02% |
+8,536
| New | +$311K |
|
|
ADMS
535
DELISTED
Adamas Pharmaceuticals
ADMS
| $226K | 0.02% |
78,300
-14,804
| -16% | -$66.3K |
|
|
DOO
536
Bombardier Recreational Products
DOO
$4.58B
| $223K | 0.02% |
+13,617
| New | +$558K |
|
|
KW
537
DELISTED
Kennedy-Wilson Holdings
KW
| $223K | 0.02% |
+16,650
| New | +$332K |
|
538
AutoZone
AZO
$49.1B
| $222K | 0.02% |
263
+18
| +7% | +$18.7K |
|
539
Protagonist Therapeutics
PTGX
$8.92B
| $222K | 0.02% |
31,421
-11,985
| -28% | -$89.8K |
|
540
First American
FAF
$7.71B
| $221K | 0.02% |
+5,200
| New | +$297K |
|
541
Landstar System
LSTR
$5.75B
| $220K | 0.02% |
+2,300
| New | +$245K |
|
542
Shenandoah Telecom
SHEN
$631M
| $220K | 0.02% |
+4,457
| New | +$198K |
|
543
Interparfums
IPAR
$4.02B
| $218K | 0.02% |
+4,700
| New | +$294K |
|
544
NWPX Infrastructure Inc
NWPX
$1.22B
| $218K | 0.02% |
+9,806
| New | +$299K |
|
545
Vera Bradley
VRA
$99.2M
| $218K | 0.02% |
52,826
+9,633
| +22% | +$81.7K |
|
|
TGH
546
DELISTED
Textainer Group Holdings limited
TGH
| $218K | 0.02% |
26,548
+15,490
| +140% | +$141K |
|
547
Precision BioSciences
DTIL
$181M
| $217K | 0.02% |
+1,199
| New | +$314K |
|
548
Novanta
NOVT
$4.95B
| $217K | 0.02% |
2,714
-496
| -15% | -$44.3K |
|
|
SDC
549
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $216K | 0.02% |
+46,230
| New | +$456K |
|
|
PVG
550
DELISTED
PRETIUM RESOURCES INC.
PVG
| $216K | 0.02% |
+38,085
| New | +$326K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q1 2020 Portfolio in Review
As of Q1 2020, PDT Partners held 929 positions worth $1.26B, down 22% from $1.62B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
PDT Partners deployed $131M of net new capital in Q1 2020, opening 226 new positions and adding to 255 existing holdings. Its largest new stake was GE Aerospace: 196,102 shares worth $7.76M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Paylocity, an estimated $8.99M trimmed.
- PDT Partners's largest Q1 2020 buy was GE Aerospace: 196,102 shares worth $7.76M.
- PDT Partners added most to AbbVie in Q1 2020, an estimated $27.2M increase.
- PDT Partners's biggest Q1 2020 reduction was Paylocity, cutting an estimated $8.99M.
- PDT Partners fully exited Bristol-Myers Squibb in Q1 2020, selling an estimated $10.8M.
- PDT Partners's ten largest holdings make up 15% of its $1.26B portfolio in Q1 2020.
- PDT Partners opened 226 new positions and closed 293 in Q1 2020.
- PDT Partners's portfolio value fell 22% quarter-over-quarter to $1.26B.
Based on PDT Partners's 13F filing for Q1 2020, filed 15 May 2020.